News & Events

• February 1, 2022
  

  C-Path and the European Joint Programme on Rare Diseases to Expand Global Impact and Partnership

  C-Path and the European Joint Programme on Rare Diseases (EJP RD), an initiative that has received funding from the European Union’s Horizon 2020 research and innovation programme, have announced a collaboration to advance technologies and methodologies that are fit for regulatory purposes to further global rare disease research and drug development.

• August 18, 2021
  

  C-Path Selects Arizona Financial Leader, former U.S. Embassy Finance Director, as CFO

  Critical Path Institute (C-Path) is pleased to announce that it has selected Kevin Perkins as its new Chief Financial Officer, effective August 9, 2021.

  Perkins comes to C-Path after serving as Associate Vice President of Finance and Global Operations with the University of Arizona (UA) where he directly managed a multi-million-dollar budget with additional responsibilities of top-line annual revenue marked to flow through the university. Prior to that he served as Director of Finance for the U.S. Embassy in Guatemala, where he had full oversight of annual budgets of nearly $100 million for dozens of federal programs, funding sources and indirect cost pools for U.S. government foreign policy programs, foreign aid and administrative operations.

• July 15, 2021
  

  Launch of UNITE4TB Partnership Marks a New Era in Tuberculosis Treatment Development

  To advance anti-tuberculosis (TB) science and enable the progression of new, safe, and affordable treatment solutions for TB patients worldwide, a new consortium of 30 partners from 13 countries has officially launched. The 7-year, €185 million project called UNITE4TB, aims to accelerate and improve the clinical evaluation of combinations of existing and novel drugs, with the goal of developing new and highly active TB treatment regimens for drug-resistant and -sensitive TB.

• July 8, 2021
  

  C-Path Announces Health Care Leader Appointment to Board of Directors

  TUCSON, Ariz., July 8, 2021 — Critical Path Institute today announced the appointment of health care industry leader and active civic involvement pioneer Mara G. Aspinall, MBA, to its Board of Directors.

• May 19, 2021
  

  C-Path Welcomes Alphabet Clinical Policy and Strategy Head, Former FDA Commissioner to Board

  TUCSON, Ariz., May 19, 2021 — Critical Path Institute today announced the appointment of Robert M. Califf, MD, MACC, head of Clinical Policy and Strategy for Google parent company Alphabet’s Verily Life Sciences and Google Health divisions, to C-Path’s Board of Directors. Califf served as the U.S. Food and Drug Administration (FDA) Commissioner under President Barack Obama’s administration from 2016-2017.